IHAM
Integral Health Asset Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-40,000
| Closed | -$11.1M | – | 76 |
|
2023
Q1 | $11.1M | Buy |
+40,000
| New | +$11.1M | 2.24% | 13 |
|
2022
Q4 | – | Sell |
-50,000
| Closed | -$13.4M | – | 66 |
|
2022
Q3 | $13.4M | Buy |
+50,000
| New | +$13.4M | 2.59% | 13 |
|
2022
Q2 | – | Sell |
-15,000
| Closed | -$3.16M | – | 69 |
|
2022
Q1 | $3.16M | Sell |
15,000
-20,000
| -57% | -$4.21M | 0.82% | 43 |
|
2021
Q4 | $8.4M | Buy |
+35,000
| New | +$8.4M | 2.32% | 13 |
|
2021
Q3 | – | Sell |
-35,000
| Closed | -$12.1M | – | 78 |
|
2021
Q2 | $12.1M | Buy |
+35,000
| New | +$12.1M | 3.34% | 6 |
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$2.45M | – | 74 |
|
2020
Q4 | $2.45M | Buy |
+10,000
| New | +$2.45M | 0.73% | 42 |
|